Europe - Euronext Paris - EPA:EAPI - FR0014008VX5 - Common Stock
The current stock price of EAPI.PA is 2.15 EUR. In the past month the price decreased by -5.83%. In the past year, price decreased by -27.93%.
ChartMill assigns a fundamental rating of 3 / 10 to EAPI.PA. The financial health of EAPI.PA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months EAPI.PA reported a non-GAAP Earnings per Share(EPS) of -1.31. The EPS increased by 56.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.62% | ||
| ROE | -13.04% | ||
| Debt/Equity | 0.07 |
13 analysts have analysed EAPI.PA and the average price target is 2.71 EUR. This implies a price increase of 25.96% is expected in the next year compared to the current price of 2.15.
For the next year, analysts expect an EPS growth of 0.35% and a revenue growth -3.72% for EAPI.PA
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SAN.PA | SANOFI | 10.27 | 189.53B | ||
| 1SAN.MI | SANOFI | 10.38 | 191.62B | ||
| SNW.DE | SANOFI | 10.4 | 190.86B | ||
| 1MRK.MI | MERCK KGAA | 15.21 | 56.39B | ||
| MRK.DE | MERCK KGAA | 14.72 | 54.59B | ||
| UNC.DE | UCB SA | 40.44 | 50.49B | ||
| UCB.BR | UCB SA | 39.94 | 49.87B | ||
| 1BAYN.MI | BAYER AG-REG | 8.33 | 43.72B | ||
| BAYN.DE | BAYER AG-REG | 8.04 | 42.16B | ||
| IPN.PA | IPSEN | 12.96 | 11.16B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 107.21 | 9.93B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 24.1 | 9.93B |
EUROAPI SA engages in manufacturing and supply of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,428 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
EUROAPI SASU
15, rue Traversiere
Paris ILE-DE-FRANCE FR
Employees: 3187
Phone: 33189206200
EUROAPI SA engages in manufacturing and supply of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,428 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
The current stock price of EAPI.PA is 2.15 EUR. The price decreased by -4.87% in the last trading session.
EAPI.PA does not pay a dividend.
EAPI.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
EAPI.PA stock is listed on the Euronext Paris exchange.
EUROAPI SASU (EAPI.PA) operates in the Health Care sector and the Pharmaceuticals industry.
EUROAPI SASU (EAPI.PA) has a market capitalization of 205.52M EUR. This makes EAPI.PA a Micro Cap stock.